NCT01484925View on ClinicalTrials.gov

BETERNet Notch Signaling and Novel Biomarkers for Barretts Esophagus

CompletedOBSERVATIONAL
Enrollment

60

Participants

Timeline

Start Date

November 30, 2011

Primary Completion Date

November 30, 2018

Study Completion Date

November 30, 2018

Conditions
Barrett's Esophagus
Trial Locations (1)

19104

Abramson Cancer Center, Philadelphia

All Listed Sponsors
lead

Abramson Cancer Center at Penn Medicine

OTHER

NCT01484925 - BETERNet Notch Signaling and Novel Biomarkers for Barretts Esophagus | Biotech Hunter | Biotech Hunter